Relapse after complete response to anthracycline‐based combination chemotherapy in metastatic breast cancer Lajos PusztaiLina AsmarGabriel N. Hortobagyi OriginalPaper Pages: 1 - 8
Cytokine‐regulated urokinase‐type‐plasminogen‐activator (uPA) production by human breast fibroblasts in vitro Anieta M. SieuwertsJan G.M. KlijnJohn A. Foekens OriginalPaper Pages: 9 - 20
Genetic anticipation and breast cancer: a prospective follow‐up study Andrew D. PatersonDavid M.J. NaimarkThomas A. Sellers OriginalPaper Pages: 21 - 28
Differential regulation of normal and tumoral breast epithelial cell growth by fibroblasts and 1,25‐dihydroxyvitamin D3 Cécile GacheYolande BerthoisSimone Saez OriginalPaper Pages: 29 - 39
α2‐Adrenergic effect on human breast cancer MCF‐7 cells Stella Maris VázquezOmar PignataroIsabel Alicia Luthy OriginalPaper Pages: 41 - 49
Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial O. KlokeU. KlaassenR. Becher OriginalPaper Pages: 51 - 59
Prognostic significance of Ki‐67 and topoisomerase IIα expression in infiltrating ductal carcinoma of the breast Pierre RudolphGaëtan MacGroganReza Parwaresch OriginalPaper Pages: 61 - 71
Differential effects of chemotherapeutic agents on the Bcl‐2/Bax apoptosis pathway in human breast cancer cell line MCF‐7 Lai K. LeungThomas T.Y. Wang OriginalPaper Pages: 73 - 83
Mutation analysis of the putative tumor suppression gene PTEN/MMAC1 in sporadic breast cancer Shou‐Tung ChenShi‐Yau YuJan‐Gowth Chang OriginalPaper Pages: 85 - 89
Phase II of doxorubicin/taxol in metastatic breast cancer Claudia PazosElizabeth MickiewiczAlbertoi Suárez OriginalPaper Pages: 91 - 96
Contrast‐enhanced computed tomography detection of occult breast cancers presenting as axillary masses Sadako Akashi‐TanakaTakashi FukutomiHitoshi Tsuda OriginalPaper Pages: 97 - 101
